Ed Geuns, speaking at World Influenza Congress Europe 2011

Ed Geuns,
Director Regulatory Affairs Vaccines EPD
Abbott Biologicals

Ed Geuns is Director Regulatory Affairs, Vaccines, at Abbott Biologicals B.V. in Weesp, the Netherlands.

He was awarded a MSc degree in pharmacy by the University of Leiden and a PharmD degree by the University of Utrecht.

From 1990 until 1997 he was (senior) chemical-pharmaceutical assessor for the Medicines Evaluation Board in the Netherlands (MEB) and the European Agency for the Evaluation of Medicinal Products (EMEA) at the Department of Human Drug Registration, Laboratory for Quality Control of Medicines (LGO), a subdivision of the National Institute for Public Health and the Environment (RIVM) in the Netherlands.

In 1997 Ed joined the Department of Regulatory Affairs Europe of Solvay Pharmaceuticals B.V. in Weesp, The Netherlands, where he held roles of increasing responsibility. He took his current position within Abbott (Established Products Division) in November 2010.

Ed represents Abbott in the Regulatory Working Groups of the European Vaccine Manufacturers (EVM) and the Influenza Vaccines Supply Task Force (IVS) of IFPMA, and he is a member of The Organisation of Professionals in Regulatory Affairs (TOPRA).

Appearing:

Congress Day 1 – Tuesday 6th December 2011

1pm

The changing regulatory landscape for influenza vaccines

A decade of change: 1991-2011
Changes in EU guidance, annual update studies and new requirements for BRIC countries
The rise of adjuvants and pre-pandemic vaccines – how exactly they have changed the ‘Big Picture’ of influenza vaccines
Looking forward – what changes, both regulatory and scientific, will the next decade bring?

Ed Geuns,

Director Regulatory Affairs Vaccines EPD,
Abbott Biologicals

Sponsor World Influenza Congress Europe 2011 ›

Silver Sponsor